Seeking Alpha

  Sarepta Therapeutics, Inc. - NASDAQ

11/26/2014, 12:33 PM ET
  • SafisKusai | Send Message 7 Oct 2013

    $SRPT looooooong DB says with ETEP approval and drugs in pipe could be worth $200
      SRPT vs. ETF Alternatives
      Company Description
      Sarepta Therapeutics Inc discovers and develops RNA-based therapeutics for the treatment of rare and infectious diseases. Its product candidates include eteplirsen, AVI-6002, AVI-6003, and AVI-7100.
      Sector: Healthcare
      Industry: Biotechnology
      Country: United States